Titan Pharma (TTNP) to Sell Up to $20M in Common Stock Through Cantor

September 1, 2016 4:09 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Titan Pharma (NASDAQ: TTNP) entered into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co., as agent, pursuant to which the Company may offer and sell, from time to time through Cantor, shares of the Company’s common stock, par value $0.001 per share, having an aggregate offering price of up to $20.0 million.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Equity Offerings

Related Entities

Cantor Fitzgerald

Add Your Comment